LRIG1, His, Mouse
LRIG1, His, Mouse

The purity of LRG1, His, Mouse is greater than 90% as determined by SEC-HPLC.

LRIG1, His, Mouse

LRG1, His, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

LRIG1, His, Mouse

The leucine-rich repeats and immunoglobulin-like domains (LRIG)-1 is a tumor suppressor gene that belongs to the LRIG family. LRIG1 expression has prognostic significance in various human cancers. Somatic mutations, which are associated with a certain rate of response to targeted therapies, are ubiquitously found in human non-small cell lung cancer (NSCLC). LRIG1 was an independent prognostic factor for OS of NSCLC patients. LRIG1 in combination with other clinicopathological risk factors was a stronger prognostic model than clinicopathological risk factors alone.
Z06248
¥72,752.00

Ask us a question
Product Introduction
Species Mouse
Protein Construction
LRIG1 (Ala35-Thr794)_x000D_
Accession # P70193		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 90% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 84.7 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 85-110 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • LRIG1, His, Mouse
    • LRIG1, His, Mouse

    The purity of LRG1, His, Mouse is greater than 90% as determined by SEC-HPLC.

  • LRIG1, His, Mouse
    • LRIG1, His, Mouse

    LRG1, His, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background The leucine-rich repeats and immunoglobulin-like domains (LRIG)-1 is a tumor suppressor gene that belongs to the LRIG family. LRIG1 expression has prognostic significance in various human cancers. Somatic mutations, which are associated with a certain rate of response to targeted therapies, are ubiquitously found in human non-small cell lung cancer (NSCLC). LRIG1 was an independent prognostic factor for OS of NSCLC patients. LRIG1 in combination with other clinicopathological risk factors was a stronger prognostic model than clinicopathological risk factors alone.
Synonyms LIG-1; LIG1; LRIG1; D6Bwg0781e; Img

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.